Below are the most recent publications written about "Delayed-Action Preparations" by people in Profiles.
-
Wang LS, Gopalakrishnan S, Luther DC, Rotello VM. Protein-Based Films as Antifouling and Drug-Eluting Antimicrobial Coatings for Medical Implants. ACS Appl Mater Interfaces. 2021 Oct 13; 13(40):48301-48307.
-
O'Sullivan DL, Byatt N, Dossett EC. Long-Acting Injectable Antipsychotic Medications in Pregnancy: A Review. J Acad Consult Liaison Psychiatry. 2022 Jan-Feb; 63(1):53-60.
-
Shirk SD, Ameral V, Kraus SW, Houchins J, Kelly M, Pugh K, Reilly E, Desai N. Buprenorphine Naloxone and Extended Release Injectable Naltrexone for the Treatment of Opioid Use Disorder Among a Veteran Patient Sample: A Retrospective Chart Review. J Dual Diagn. 2021 Jul-Sep; 17(3):207-215.
-
Sharma M, Bhat R, Usmani Z, McClements DJ, Shukla P, Raghavendra VB, Gupta VK. Bio-Based Formulations for Sustainable Applications in Agri-Food-Pharma. Biomolecules. 2021 05 20; 11(5).
-
Reinstein SA, Cosgrove J, Malekshahi T, Deligiannidis KM. Long-Acting Injectable Antipsychotic Use During Pregnancy: A Brief Review and Concise Guide for Clinicians. J Clin Psychiatry. 2020 11 24; 81(6).
-
Pivovarova E, Min HS, Friedmann PD. Impact of extended release naltrexone on health-related quality of life in individuals with legal involvement and opioid use disorders. Subst Abus. 2021; 42(4):618-624.
-
Jeffery MM, Chaisson CE, Hane C, Rumanes L, Tucker J, Hang L, McCoy R, Chen CL, Bicket MC, Hooten WM, Larochelle M, Becker WC, Kornegay C, Racoosin JA, Sanghavi D. Assessment of Potentially Inappropriate Prescribing of Opioid Analgesics Requiring Prior Opioid Tolerance. JAMA Netw Open. 2020 04 01; 3(4):e202875.
-
Yao M, Xie J, Du H, McClements DJ, Xiao H, Li L. Progress in microencapsulation of probiotics: A review. Compr Rev Food Sci Food Saf. 2020 03; 19(2):857-874.
-
Johnson ER, Taylor AR, Boothe DM, Gray-Edwards HL, Winter RL, Martin DR. Pharmacokinetics of a commercially available product and a compounded formulation of extended-release levetiracetam after oral administration of a single dose in cats. Am J Vet Res. 2019 Oct; 80(10):950-956.
-
Yant SR, Mulato A, Hansen D, Tse WC, Niedziela-Majka A, Zhang JR, Stepan GJ, Jin D, Wong MH, Perreira JM, Singer E, Papalia GA, Hu EY, Zheng J, Lu B, Schroeder SD, Chou K, Ahmadyar S, Liclican A, Yu H, Novikov N, Paoli E, Gonik D, Ram RR, Hung M, McDougall WM, Brass AL, Sundquist WI, Cihlar T, Link JO. A highly potent long-acting small-molecule HIV-1 capsid inhibitor with efficacy in a humanized mouse model. Nat Med. 2019 09; 25(9):1377-1384.